NF-κB2 was upregulated 1.720-fold in B-CLL, 8.545-fold in B-cell NHL, 16.257-fold in AML, and 1.676-fold in HCL cases. This evidence concerns the gene NFKB2 and B-cell non-Hodgkin lymphoma.